NCT06594198 (ARGOS Platform) is a NA clinical trial of Cerebral monitor in Brain Monitor, sponsored by Braindex.

Who is sponsoring NCT06594198?

NCT06594198 is sponsored by Braindex.

What drugs are being tested in NCT06594198?

Interventions in NCT06594198: Cerebral monitor.

What condition does NCT06594198 study?

NCT06594198 studies Brain Monitor, Anaesthesia.

Is NCT06594198 still recruiting?

NCT06594198 is currently completed. Last updated 16 May 2025.

Last reviewed 2025-05-16 · How we verify

NCT06594198: ARGOS Platform

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study

Completed NA Last updated 16 May 2025

What this trial tests

NA trial testing Cerebral monitor in Brain Monitor in 40 participants. Completed in 3 March 2025.

Timeline

9 September 2024

Primary endpoint
9 September 2024

3 March 2025

Quick facts

Lead sponsor	Braindex
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	40
Start date	9 September 2024
Primary completion	9 September 2024
Estimated completion	3 March 2025
Sites	1 location across France

Drugs / interventions tested

Cerebral monitor

Conditions studied

Brain Monitor — all drugs for Brain Monitor →
Anaesthesia — all drugs for Anaesthesia →

Sponsor

Braindex

Who can join

18 and older, any sex, with Brain Monitor or Anaesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to show the concordance of the SctO2 values of the ARGOS platform with the standard SctO2 values (comparative study with platform INVOS, Medtronic).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Braindex trials

Trials by the same sponsor.

NCT05897060 — Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Assessment and Improvement · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06594198 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Braindex
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594198.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing